JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, H. B.
Right arrow Articles by Choe, K. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, H. B.
Right arrow Articles by Choe, K. W.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, June 2003, p. 2279-2281, Vol. 41, No. 6
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.6.2279-2281.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Nationwide Surveillance for Staphylococcus aureus with Reduced Susceptibility to Vancomycin in Korea

Hong Bin Kim,1 Wan Beom Park,1 Ki Deok Lee,1 Young Joo Choi,1 Sang Won Park,1 Myoung-don Oh,1,2* Eui-Chong Kim,2,3 and Kang Won Choe1,2

Departments of Internal Medicine,1 Laboratory Medicine, Seoul National University College of Medicine,3 Clinical Research Institute, Seoul National University Hospital, Seoul 110-744, Republic of Korea2

Received 21 January 2003/ Returned for modification 18 February 2003/ Accepted 6 March 2003

Methicillin-resistant Staphylococcus aureus (MRSA) accounts for more than 70% of S. aureus isolates from tertiary hospitals in Korea. Clinical isolates of S. aureus were collected from eight provincial, university-affiliated hospitals during the period from June 1999 to January 2001 for nationwide surveillance. All isolates were screened for reduced susceptibility to vancomycin by using brain heart infusion agar containing 4 µg of vancomycin per milliliter. Population analysis and the determination of the MIC of vancomycin were done for the isolates which grew on the screening agar plates. Of 682 total isolates, MRSA accounted for 64% (439 of 682). Of 27 (4%) isolates that grew on the screening agar plates, none showed the heteroresistance phenotype. No strains with reduced susceptibility to vancomycin were identified.


* Corresponding author. Mailing address: Department of Internal Medicine, Seoul National University College of Medicine, 28 Yeongun-dong, Chongro-gu, Seoul 110-744, Republic of Korea. Phone: 82-2-760-2945. Fax: 82-2-762-9662. E-mail: mdohmd{at}snu.ac.kr.


Journal of Clinical Microbiology, June 2003, p. 2279-2281, Vol. 41, No. 6
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.6.2279-2281.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2003 by the American Society for Microbiology. All rights reserved.